Sexually transmitted diseases reach record high in U.S., says CDC


Cases of chlamydia, gonorrhea, and syphilis reached a record high in 2017, the Centers for Disease Control and Prevention reported Tuesday, with 2.3 million diagnosed cases.
The rapid rise may be in part due to a decrease in condom use and mutating strains of infections that resist antibiotics. "We have seen steep and sustained increases over the last five years,” Gail Bolan, director of the CDC's Division of STD Prevention, told NBC News. "Usually there are ebbs and flows, but this sustained increase is very concerning."
Gonorrhea diagnoses increased 67 percent between 2013 and 2017, while syphilis diagnoses increased 76 percent. The rate of chlamydia, the STD most often reported to the CDC, has remained fairly steady, but the prevalence of all three diseases broke previous 2016 records. The most recent data showed an increase of more than 200,000 cases in just one year.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We are sliding backward," said Jonathan Mermin, director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. "It is evident the systems that identify, treat, and ultimately prevent STDs are strained to near-breaking point." Read more at NBC News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Summer Meza has worked at The Week since 2018, serving as a staff writer, a news writer and currently the deputy editor. As a proud news generalist, she edits everything from political punditry and science news to personal finance advice and film reviews. Summer has previously written for Newsweek and the Seattle Post-Intelligencer, covering national politics, transportation and the cannabis industry.
-
The state of Britain's Armed Forces
The Explainer Geopolitical unrest and the unreliability of the Trump administration have led to a frantic re-evaluation of the UK's military capabilities
By The Week UK
-
Anti-anxiety drug has a not-too-surprising effect on fish
Under the radar The fish act bolder and riskier
By Devika Rao, The Week US
-
Crossword: April 21, 2025
The Week's daily crossword
By The Week Staff
-
Hantavirus: the rare pathogen linked to rodents that attacks the lungs
The Explainer Despite the low risk of contracting it, the virus could be potentially deadly
By Theara Coleman, The Week US
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
By Peter Weber, The Week US
-
What does Health and Human Services do?
The Explainer Cuts will 'dramatically alter' public health in America
By Joel Mathis, The Week US
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
By Peter Weber, The Week US
-
Tuberculosis sees a resurgence and is only going to get worse
Under the radar The spread of the deadly infection is buoyed by global unrest
By Devika Rao, The Week US
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US
-
MAHA moms: the cohort of women backing RFK Jr.'s health agenda
The Explainer America's head health honcho has a flock of supporters spreading the MAHA message on social media
By Theara Coleman, The Week US
-
The banned pesticide poisoning Caribbean paradise
Under the radar Martinique and Guadeloupe have been rocked by soaring cancer rates amid other diagnoses
By Rebekah Evans, The Week UK